Vadivarhe Speciality Chemicals Ltd
₹ 27.0
1.12%
17 Apr
- close price
About
Incorporated in 2009, Vadivarhe Speciality Chemicals Ltd is in the business of manufacturing Specialty Chemicals, Intermediates & API
Key Points
- Market Cap ₹ 34.5 Cr.
- Current Price ₹ 27.0
- High / Low ₹ 75.4 / 21.0
- Stock P/E 67.7
- Book Value ₹ 2.49
- Dividend Yield 0.00 %
- ROCE 10.2 %
- ROE 1.24 %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 10.8 times its book value
- Company has low interest coverage ratio.
- Promoter holding has decreased over last quarter: -3.12%
- The company has delivered a poor sales growth of 4.37% over past five years.
- Company has a low return on equity of -40.2% over last 3 years.
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
13.16 | 13.87 | 19.03 | 26.28 | 35.03 | 25.56 | 32.36 | 28.58 | 26.47 | 21.45 | 43.68 | 40.08 | 40.45 | |
15.41 | 11.18 | 11.52 | 18.89 | 24.64 | 21.80 | 29.97 | 37.82 | 27.01 | 28.24 | 40.22 | 35.48 | 37.45 | |
Operating Profit | -2.25 | 2.69 | 7.51 | 7.39 | 10.39 | 3.76 | 2.39 | -9.24 | -0.54 | -6.79 | 3.46 | 4.60 | 3.00 |
OPM % | -17.10% | 19.39% | 39.46% | 28.12% | 29.66% | 14.71% | 7.39% | -32.33% | -2.04% | -31.66% | 7.92% | 11.48% | 7.42% |
0.05 | 0.11 | 0.11 | 0.14 | 1.05 | 0.45 | 0.40 | 0.37 | 1.08 | 0.66 | 1.09 | 0.47 | 0.41 | |
Interest | 1.10 | 1.02 | 0.89 | 1.21 | 0.85 | 0.77 | 1.11 | 1.37 | 1.32 | 1.69 | 1.61 | 1.83 | 1.15 |
Depreciation | 1.69 | 1.65 | 1.09 | 1.36 | 1.14 | 1.27 | 1.63 | 1.75 | 1.81 | 1.79 | 1.79 | 1.74 | 1.75 |
Profit before tax | -4.99 | 0.13 | 5.64 | 4.96 | 9.45 | 2.17 | 0.05 | -11.99 | -2.59 | -9.61 | 1.15 | 1.50 | 0.51 |
Tax % | -32.06% | 46.15% | 29.61% | 13.51% | 36.51% | 18.43% | -20.00% | -17.93% | 6.56% | 0.00% | 0.00% | 96.67% | |
-3.39 | 0.07 | 3.98 | 4.29 | 6.01 | 1.77 | 0.06 | -9.84 | -2.76 | -9.61 | 1.15 | 0.06 | 0.51 | |
EPS in Rs | -70.07 | 1.45 | 82.27 | 88.67 | 4.97 | 1.38 | 0.05 | -7.70 | -2.16 | -7.52 | 0.90 | 0.05 | 0.40 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 11% |
5 Years: | 4% |
3 Years: | 15% |
TTM: | 11% |
Compounded Profit Growth | |
---|---|
10 Years: | 1% |
5 Years: | -8% |
3 Years: | 26% |
TTM: | 116% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 34% |
3 Years: | 14% |
1 Year: | -34% |
Return on Equity | |
---|---|
10 Years: | -4% |
5 Years: | -37% |
3 Years: | -40% |
Last Year: | 1% |
Balance Sheet
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 4.84 | 4.84 | 4.84 | 4.84 | 12.09 | 12.78 | 12.78 | 12.78 | 12.78 | 12.78 | 12.78 | 12.78 | 12.78 |
Reserves | 5.66 | 5.73 | 9.68 | 12.62 | 11.38 | 14.64 | 14.70 | 4.87 | 2.11 | -7.50 | -6.36 | -6.29 | -9.60 |
16.77 | 14.35 | 11.24 | 10.65 | 12.74 | 9.66 | 20.98 | 19.67 | 23.45 | 24.42 | 26.94 | 26.18 | 31.36 | |
4.26 | 7.75 | 3.67 | 5.09 | 9.52 | 7.13 | 9.28 | 14.00 | 8.84 | 11.97 | 13.08 | 8.94 | 6.40 | |
Total Liabilities | 31.53 | 32.67 | 29.43 | 33.20 | 45.73 | 44.21 | 57.74 | 51.32 | 47.18 | 41.67 | 46.44 | 41.61 | 40.94 |
17.79 | 15.93 | 15.02 | 13.96 | 17.12 | 19.68 | 26.09 | 25.20 | 25.98 | 24.32 | 23.36 | 21.59 | 21.89 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.09 | 1.58 | 1.88 | 2.81 | 0.33 | 1.09 | 0.99 | 1.56 | 1.58 |
Investments | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 |
13.69 | 16.69 | 14.36 | 19.19 | 28.47 | 22.90 | 29.72 | 23.26 | 20.82 | 16.21 | 22.04 | 18.41 | 17.42 | |
Total Assets | 31.53 | 32.67 | 29.43 | 33.20 | 45.73 | 44.21 | 57.74 | 51.32 | 47.18 | 41.67 | 46.44 | 41.61 | 40.94 |
Cash Flows
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
-2.83 | 6.41 | 5.27 | 3.18 | 2.09 | 7.15 | -1.22 | 4.10 | -0.28 | 1.24 | -0.35 | 2.26 | |
-1.03 | 0.00 | -0.18 | -0.64 | -4.33 | -5.32 | -8.27 | -1.68 | 0.02 | -0.82 | -0.69 | -0.51 | |
3.87 | -6.19 | -4.01 | -3.43 | 1.88 | -1.12 | 9.25 | -2.34 | 0.58 | -0.60 | 1.05 | -2.04 | |
Net Cash Flow | 0.02 | 0.22 | 1.07 | -0.89 | -0.37 | 0.70 | -0.23 | 0.08 | 0.32 | -0.18 | 0.00 | -0.29 |
Ratios
Figures in Rs. Crores
Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 71.56 | 135.00 | 70.97 | 117.50 | 159.63 | 122.95 | 143.25 | 104.34 | 125.62 | 34.37 | 48.22 | 44.99 |
Inventory Days | 188.83 | 223.98 | 221.86 | 116.68 | 61.66 | 170.63 | 221.62 | 122.32 | 77.40 | 168.42 | 120.82 | 147.37 |
Days Payable | 146.00 | 128.58 | 50.10 | 108.01 | 115.85 | 120.38 | 174.61 | 205.42 | 152.95 | 218.56 | 145.63 | 122.81 |
Cash Conversion Cycle | 114.38 | 230.40 | 242.73 | 126.18 | 105.44 | 173.20 | 190.26 | 21.24 | 50.07 | -15.76 | 23.40 | 69.55 |
Working Capital Days | 85.70 | 76.84 | 102.23 | 86.67 | 140.56 | 143.80 | 155.66 | 61.30 | 76.25 | 37.95 | 56.07 | 81.96 |
ROCE % | -14.79% | 4.41% | 25.77% | 22.61% | 29.66% | 7.86% | 2.88% | -25.06% | -5.34% | -24.02% | 7.61% | 10.15% |
Documents
Announcements
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
15 April 2025 - No rematerialisation requests; all shares in demat form for Mar 2025 quarter.
-
Trading Window-XBRL
26 March 2025 - Vadivarhe Speciality Chemicals Limited has informed about Closure of Trading Window
-
Trading Window
26 March 2025 - Trading window closed April 1, 2025 until 48 hours after Q4 FY25 audited results
-
Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
12 February 2025 - VADIVARHE SPECIALITY CHEMICALS LIMITED has informed about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent
-
Resignation
12 February 2025 - Resignation of CFO Mr. Laxmikant Potdar effective May 31, 2025.
Business Overview:[1][2]
Company manufactures Active Pharmaceutical Ingredients, bulk drugs, special chemicals, Organic Chemicals, Inorganic Chemicals, Bio-Chemicals and Drug Intermediaries. Raw materials are procured primarily from local market and imported from China. Further, finished products of VSCL are sold locally and
also exported to the countries viz, UK,
USA, Switzerland and Malaysia. Company's manufacturing unit is located at Nashik
with an installed capacity of 150 MTPA